Advanced search
1 file | 135.64 KB

Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease

Karen Heyninck (UGent) , Andy Wullaert (UGent) and Rudi Beyaert (UGent)
(2003) BIOCHEMICAL PHARMACOLOGY. 66(8). p.1409-1415
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 135.64 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Heyninck, Karen, Andy Wullaert, and Rudi Beyaert. 2003. “Nuclear Factor-kappa B Plays a Central Role in Tumour Necrosis Factor-mediated Liver Disease.” Biochemical Pharmacology 66 (8): 1409–1415.
APA
Heyninck, K., Wullaert, A., & Beyaert, R. (2003). Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. BIOCHEMICAL PHARMACOLOGY, 66(8), 1409–1415.
Vancouver
1.
Heyninck K, Wullaert A, Beyaert R. Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. BIOCHEMICAL PHARMACOLOGY. 2003;66(8):1409–15.
MLA
Heyninck, Karen, Andy Wullaert, and Rudi Beyaert. “Nuclear Factor-kappa B Plays a Central Role in Tumour Necrosis Factor-mediated Liver Disease.” BIOCHEMICAL PHARMACOLOGY 66.8 (2003): 1409–1415. Print.
@article{211936,
  author       = {Heyninck, Karen and Wullaert, Andy and Beyaert, Rudi},
  issn         = {0006-2952},
  journal      = {BIOCHEMICAL PHARMACOLOGY},
  language     = {eng},
  number       = {8},
  pages        = {1409--1415},
  title        = {Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease},
  url          = {http://dx.doi.org/10.1016/S0006-2952(03)00491-X},
  volume       = {66},
  year         = {2003},
}

Altmetric
View in Altmetric
Web of Science
Times cited: